Exact Mass: 457.2593110000001
Exact Mass Matches: 457.2593110000001
Found 144 metabolites which its exact mass value is equals to given mass value 457.2593110000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
10,11-Dihydro-12R-hydroxy-leukotriene E4
C23H39NO6S (457.24979540000004)
10,11-dihydro-12R-hydroxy-leukotriene E4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 10,11-dihydro-12R-hydroxy-leukotriene E4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078)
CENTCHROMAN
C30H35NO3 (457.26168000000007)
Asp Lys Pro Val
C20H35N5O7 (457.25363600000003)
Asp Lys Val Pro
C20H35N5O7 (457.25363600000003)
Asp Pro Lys Val
C20H35N5O7 (457.25363600000003)
Asp Pro Val Lys
C20H35N5O7 (457.25363600000003)
Asp Val Lys Pro
C20H35N5O7 (457.25363600000003)
Asp Val Pro Lys
C20H35N5O7 (457.25363600000003)
Ile Pro Gln Thr
C20H35N5O7 (457.25363600000003)
Ile Pro Thr Gln
C20H35N5O7 (457.25363600000003)
Ile Gln Pro Thr
C20H35N5O7 (457.25363600000003)
Ile Gln Thr Pro
C20H35N5O7 (457.25363600000003)
Ile Thr Pro Gln
C20H35N5O7 (457.25363600000003)
Ile Thr Gln Pro
C20H35N5O7 (457.25363600000003)
Lys Asp Pro Val
C20H35N5O7 (457.25363600000003)
Lys Asp Val Pro
C20H35N5O7 (457.25363600000003)
Lys Pro Asp Val
C20H35N5O7 (457.25363600000003)
Lys Pro Val Asp
C20H35N5O7 (457.25363600000003)
Lys Val Asp Pro
C20H35N5O7 (457.25363600000003)
Lys Val Pro Asp
C20H35N5O7 (457.25363600000003)
Leu Pro Gln Thr
C20H35N5O7 (457.25363600000003)
Leu Pro Thr Gln
C20H35N5O7 (457.25363600000003)
Leu Gln Pro Thr
C20H35N5O7 (457.25363600000003)
Leu Gln Thr Pro
C20H35N5O7 (457.25363600000003)
Leu Thr Pro Gln
C20H35N5O7 (457.25363600000003)
Leu Thr Gln Pro
C20H35N5O7 (457.25363600000003)
Pro Asp Lys Val
C20H35N5O7 (457.25363600000003)
Pro Asp Val Lys
C20H35N5O7 (457.25363600000003)
Pro Ile Gln Thr
C20H35N5O7 (457.25363600000003)
Pro Ile Thr Gln
C20H35N5O7 (457.25363600000003)
Pro Lys Asp Val
C20H35N5O7 (457.25363600000003)
Pro Lys Val Asp
C20H35N5O7 (457.25363600000003)
Pro Leu Gln Thr
C20H35N5O7 (457.25363600000003)
Pro Leu Thr Gln
C20H35N5O7 (457.25363600000003)
Pro Gln Ile Thr
C20H35N5O7 (457.25363600000003)
Pro Gln Leu Thr
C20H35N5O7 (457.25363600000003)
Pro Gln Thr Ile
C20H35N5O7 (457.25363600000003)
Pro Gln Thr Leu
C20H35N5O7 (457.25363600000003)
Pro Arg Ser Val
C19H35N7O6 (457.26486900000003)
Pro Arg Val Ser
C19H35N7O6 (457.26486900000003)
Pro Ser Arg Val
C19H35N7O6 (457.26486900000003)
Pro Ser Val Arg
C19H35N7O6 (457.26486900000003)
Pro Thr Ile Gln
C20H35N5O7 (457.25363600000003)
Pro Thr Leu Gln
C20H35N5O7 (457.25363600000003)
Pro Thr Gln Ile
C20H35N5O7 (457.25363600000003)
Pro Thr Gln Leu
C20H35N5O7 (457.25363600000003)
Pro Val Asp Lys
C20H35N5O7 (457.25363600000003)
Pro Val Lys Asp
C20H35N5O7 (457.25363600000003)
Pro Val Arg Ser
C19H35N7O6 (457.26486900000003)
Pro Val Ser Arg
C19H35N7O6 (457.26486900000003)
Gln Ile Pro Thr
C20H35N5O7 (457.25363600000003)
Gln Ile Thr Pro
C20H35N5O7 (457.25363600000003)
Gln Leu Pro Thr
C20H35N5O7 (457.25363600000003)
Gln Leu Thr Pro
C20H35N5O7 (457.25363600000003)
Gln Pro Ile Thr
C20H35N5O7 (457.25363600000003)
Gln Pro Leu Thr
C20H35N5O7 (457.25363600000003)
Gln Pro Thr Ile
C20H35N5O7 (457.25363600000003)
Gln Pro Thr Leu
C20H35N5O7 (457.25363600000003)
Gln Thr Ile Pro
C20H35N5O7 (457.25363600000003)
Gln Thr Leu Pro
C20H35N5O7 (457.25363600000003)
Gln Thr Pro Ile
C20H35N5O7 (457.25363600000003)
Gln Thr Pro Leu
C20H35N5O7 (457.25363600000003)
Arg Pro Ser Val
C19H35N7O6 (457.26486900000003)
Arg Pro Val Ser
C19H35N7O6 (457.26486900000003)
Arg Ser Pro Val
C19H35N7O6 (457.26486900000003)
Arg Ser Val Pro
C19H35N7O6 (457.26486900000003)
Arg Val Pro Ser
C19H35N7O6 (457.26486900000003)
Arg Val Ser Pro
C19H35N7O6 (457.26486900000003)
Ser Pro Arg Val
C19H35N7O6 (457.26486900000003)
Ser Pro Val Arg
C19H35N7O6 (457.26486900000003)
Ser Arg Pro Val
C19H35N7O6 (457.26486900000003)
Ser Arg Val Pro
C19H35N7O6 (457.26486900000003)
Ser Val Pro Arg
C19H35N7O6 (457.26486900000003)
Ser Val Arg Pro
C19H35N7O6 (457.26486900000003)
Thr Ile Pro Gln
C20H35N5O7 (457.25363600000003)
Thr Ile Gln Pro
C20H35N5O7 (457.25363600000003)
Thr Leu Pro Gln
C20H35N5O7 (457.25363600000003)
Thr Leu Gln Pro
C20H35N5O7 (457.25363600000003)
Thr Pro Ile Gln
C20H35N5O7 (457.25363600000003)
Thr Pro Leu Gln
C20H35N5O7 (457.25363600000003)
Thr Pro Gln Ile
C20H35N5O7 (457.25363600000003)
Thr Pro Gln Leu
C20H35N5O7 (457.25363600000003)
Thr Gln Ile Pro
C20H35N5O7 (457.25363600000003)
Thr Gln Leu Pro
C20H35N5O7 (457.25363600000003)
Thr Gln Pro Ile
C20H35N5O7 (457.25363600000003)
Thr Gln Pro Leu
C20H35N5O7 (457.25363600000003)
Val Asp Lys Pro
C20H35N5O7 (457.25363600000003)
Val Asp Pro Lys
C20H35N5O7 (457.25363600000003)
Val Lys Asp Pro
C20H35N5O7 (457.25363600000003)
Val Lys Pro Asp
C20H35N5O7 (457.25363600000003)
Val Pro Asp Lys
C20H35N5O7 (457.25363600000003)
Val Pro Lys Asp
C20H35N5O7 (457.25363600000003)
Val Pro Arg Ser
C19H35N7O6 (457.26486900000003)
Val Pro Ser Arg
C19H35N7O6 (457.26486900000003)
Val Arg Pro Ser
C19H35N7O6 (457.26486900000003)
Val Arg Ser Pro
C19H35N7O6 (457.26486900000003)
Val Ser Pro Arg
C19H35N7O6 (457.26486900000003)
Val Ser Arg Pro
C19H35N7O6 (457.26486900000003)
10,11-Dihydro-12R-hydroxy-leukotriene E4
C23H39NO6S (457.24979540000004)
Ormeloxifene
C30H35NO3 (457.26168000000007)
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XC - Selective estrogen receptor modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
5,12-Dihydroxy-6-cysteinyl-7,9,14-eicosatrienoic acid
C23H39NO6S (457.24979540000004)
4-[4-[[1-(2-Methylbutan-2-yl)-5-tetrazolyl]-(6-quinolinyl)methyl]-1-piperazinyl]phenol
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-2-phenylacetamide
C24H35N5O4 (457.26889100000005)
1-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
C25H35N3O5 (457.25765800000005)
1-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-3-cyclopentylurea
C25H35N3O5 (457.25765800000005)
1-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
C25H35N3O5 (457.25765800000005)
1-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
C25H35N3O5 (457.25765800000005)
1-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
C25H35N3O5 (457.25765800000005)
(1R)-1-[2-(dimethylamino)-1-oxoethyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
C24H35N5O4 (457.26889100000005)
(1S)-1-[2-(dimethylamino)-1-oxoethyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide
C24H35N5O4 (457.26889100000005)
1-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
C25H35N3O5 (457.25765800000005)
1-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
C25H35N3O5 (457.25765800000005)
1-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-cyclopentylurea
C25H35N3O5 (457.25765800000005)
2-aminoethyl [2-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propyl] hydrogen phosphate
C23H40NO6P (457.2593110000001)
(12R)-hydroxy-10,11-dihydroleukotriene E4
C23H39NO6S (457.24979540000004)
A leukotriene with formula C23H39NO6S that results from the metabilism of leukotriene B4 by human keratinocytes.
methyl 6-chloro-5-[(7-methoxy-n-methyltetradec-4-enamido)methyl]-3-oxohex-5-enoate
C24H40ClNO5 (457.2594860000001)
(3s)-6-methyl-3-[(6r)-6-{[2-methyl-6-(methylsulfanyl)-4-oxohexan-3-yl]-c-hydroxycarbonimidoyl}-1,2-diazinane-1-carbonyl]heptanoic acid
C22H39N3O5S (457.26102840000004)
6-methyl-3-(6-{[2-methyl-6-(methylsulfanyl)-4-oxohexan-3-yl]-c-hydroxycarbonimidoyl}-1,2-diazinane-1-carbonyl)heptanoic acid
C22H39N3O5S (457.26102840000004)
methyl (5z)-6-chloro-5-{[(4e,7s)-7-methoxy-n-methyltetradec-4-enamido]methyl}-3-oxohex-5-enoate
C24H40ClNO5 (457.2594860000001)
methyl (5z)-6-chloro-5-{[(4z,7s)-7-methoxy-n-methyltetradec-4-enamido]methyl}-3-oxohex-5-enoate
C24H40ClNO5 (457.2594860000001)